Stenochlaena palustris

From WikiMD's WELLNESSPEDIA

Stenochlaena palustris is a species of fern in the family Blechnaceae. It is commonly known as the climbing fern or midrib fern. This fern is native to Asia and Oceania, and it is particularly prevalent in Southeast Asia.

Description[edit]

Stenochlaena palustris is a climbing fern that can reach up to 15 meters in length. The fronds are pinnate, with the pinnae arranged alternately along the rachis. The pinnae are linear-lanceolate in shape, with a serrated margin. The sori are located on the underside of the pinnae, along the midrib.

Habitat and Distribution[edit]

Stenochlaena palustris is found in a variety of habitats, including forests, swamps, and disturbed areas. It is particularly common in lowland rainforests and secondary forests. The fern is native to a wide range of countries in Asia and Oceania, including India, China, Indonesia, Malaysia, Philippines, Papua New Guinea, and Australia.

Uses[edit]

Stenochlaena palustris has a number of uses in traditional medicine and as a food source. The young fronds are edible and are often used in salads or cooked as a vegetable. In traditional medicine, the fern is used to treat a variety of ailments, including coughs, wounds, and skin diseases.

Conservation[edit]

While Stenochlaena palustris is not currently listed as threatened or endangered, it is subject to habitat loss due to deforestation and land conversion for agriculture. Conservation efforts are needed to ensure the survival of this species.

See Also[edit]

References[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.